Innovative Tech Offers Surgeons Live Breast Cancer Insights

MIT spinout Lumicell has developed a handheld device and optical imaging agent that provide surgeons with real-time visualization of cancerous tissue during breast cancer surgeries, reducing the need for second operations. The technology, which received FDA approval, allows surgeons to scan the surgical cavity for residual cancer cells, potentially improving outcomes. The development involved collaboration among MIT professors and was driven by personal experiences with cancer, highlighting the importance of interdisciplinary research in advancing medical technology.